Will insurance help with the bill?

Coverage: ask about your plan and the purpose

Give the plan the medicine’s precise name, whether it is a tablet or another form, and the condition written on the prescription.

The plan’s list of medicines is called its formulary. When the plan must agree beforehand to pay, that step is called prior authorization.

Ask what evidence the plan needs and what you would pay after approval.

Medicare: the reason for treatment matters

Medicare Part D, its prescription benefit, still excludes drugs used only for weight loss.

For an accepted purpose besides weight loss, payment for a medicine may be allowed; examples include diabetes care and an approved use that lowers heart risks.

The plan may still say no. Its medicine list and approval checks decide whether it pays.

Bridge: temporary help with conditions

The Medicare GLP-1 Bridge offers some adults help paying for weight-loss medicines for a limited time.

GLP-1 is a name used for this group of weight and diabetes medicines.

The patient pays a monthly share, called a copay, of $50; the program begins July 1, 2026, and ends December 31, 2027.

To qualify, adults aged 18 or older need either a separate Part D drug plan or drug coverage through a Medicare Advantage plan of a type accepted by the program. For any other plan type, qualification requires a separate Part D plan.

One way to meet the weight rule is a body mass index (BMI) of 35 or above when treatment began. BMI is a number based on your height and weight. Lower BMI levels need other health conditions. The clinician must check the program’s full health conditions and exclusions.

A prescription and the program’s permission before payment are required. People with type 2 diabetes use ordinary Part D rather than the Bridge.

A Part D payment for any of these GLP-1 medicines during 2026 bars that patient from the Bridge for 2026.

The included medicines are orforglipron (Foundayo) tablets, semaglutide (Wegovy) tablets or injections, and tirzepatide (Zepbound) in the KwikPen device. Zepbound single-dose pens and vials, the small medicine bottles, are excluded.

The usual Part D yearly limit caps what you pay for covered drugs counted toward it: $2,100 in 2026 and $2,400 in 2027. Bridge payments are separate and do not help you reach that limit.

Bridge patients keep paying $50 for each month’s supply, even after reaching their usual Part D limit. Twelve monthly supplies would cost $600. The Bridge gives no extra reduction for people with low incomes.

Ask your clinician to check all the health conditions, including your weight and other diagnoses. Ask your plan to check its plan type and any past Part D payments. Then ask which medicine and payment option fits your case.

Savings card: different from a cash offer

Copay cards from drug makers require private insurance and exclude Medicare, Medicaid and other government programs.

People with Medicare or other government insurance may still use a maker’s cash offer if they meet that offer’s terms. That is a separate offer from the savings card, and you pay outside insurance.